Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David S. Ettinger, MD
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pretoria Academic Hospitals
Pretoria, South Africa
- Veterans Affairs Medical Center - Palo Alto
Palo Alto, California, United States
- Stanford University Medical Center
Stanford, California, United States
- Ccop - Colorado Cancer Research Program, Inc.
Denver, Colorado, United States
- Sylvester Cancer Center, University of Miami
Miami, Florida, United States
- Emory University Hospital - Atlanta
Atlanta, Georgia, United States
- Veterans Affairs Medical Center - Atlanta (decatur)
Decatur, Georgia, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, Illinois, United States
- Veterans Affairs Medical Center - Lakeside Chicago
Chicago, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Veterans Affairs Medical Center - Indianapolis (roudebush)
Indianapolis, Indiana, United States
- Ccop - Cedar Rapids Oncology Project
Cedar Rapids, Iowa, United States
- Johns Hopkins Oncology Center
Baltimore, Maryland, United States
- New England Medical Center Hospital
Boston, Massachusetts, United States
- Ccop - Kalamazoo
Kalamazoo, Michigan, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- Veterans Affairs Medical Center - Albany
Albany, New York, United States
- University of Rochester Cancer Center
Rochester, New York, United States
- Albert Einstein Comprehensive Cancer Center
The Bronx, New York, United States
- Ireland Cancer Center
Cleveland, Ohio, United States
- Ccop - Geisinger Clinic and Medical Center
Danville, Pennsylvania, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Hahnemann University Hospital
Philadelphia, Pennsylvania, United States
- Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
- Veterans Affairs Medical Center - Nashville
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Oct 1998
- Primary completion
- 30 Sept 2003
- Completion
- —
- Last update posted
- 15 Jun 2023
- Registered enrollment
- 38
- Registry id
- NCT00003283
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.